SINSIN PHARMACEUTICAL Co., LTD.
002800 | KO
Overview
Corporate Details
- ISIN(s):
- KR7002800001
- LEI:
- Country:
- South Korea
- Address:
- 세종특별자치시 소정면 소정산단동로 9 -, 세종특별자치시
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
No description available.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
You have of free filing views remaining.
Upgrade for unlimited access.
Bulk Actions:
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-08-14 00:00 |
Interim / Quarterly Report
반기보고서 (2025.06)
|
Korean | 1.3 MB | ||
| 2025-05-14 00:00 |
Quarterly Report
분기보고서 (2025.03)
|
Korean | 1.1 MB | ||
| 2025-03-26 00:00 |
AGM Information
정기주주총회결과
|
Korean | 26.2 KB | ||
| 2025-03-26 00:00 |
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
|
Korean | 9.9 KB | ||
| 2025-03-18 00:00 |
Audit Report / Information
감사보고서제출
|
Korean | 24.5 KB | ||
| 2025-03-18 00:00 |
Annual / Quarterly Financial Statement
사업보고서 (2024.12)
|
Korean | 418.8 KB | ||
| 2025-03-11 00:00 |
Pre-Annual General Meeting Information
주주총회소집공고
|
Korean | 119.4 KB | ||
| 2025-03-11 00:00 |
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
|
Korean | 114.8 KB | ||
| 2025-02-05 00:00 |
Notice of Dividend Amount
현금ㆍ현물배당결정
|
Korean | 8.2 KB | ||
| 2025-02-05 00:00 |
Pre-Annual General Meeting Information
주주총회소집결의
|
Korean | 12.8 KB | ||
| 2025-01-22 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.2 KB | ||
| 2025-01-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2025-01-14 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.5 KB | ||
| 2024-12-12 00:00 |
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2024-11-14 00:00 |
Quarterly Report
분기보고서 (2024.09)
|
Korean | 1.1 MB |
Automate Your Workflow. Get a real-time feed of all SINSIN PHARMACEUTICAL Co., LTD. filings delivered via API.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
Unlock Full Financials for SINSIN PHARMACEUTICAL Co., LTD.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for SINSIN PHARMACEUTICAL Co., LTD. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
Company
Country
Ticker
View
Developing small molecule therapies targeting p53 mutations to treat cancer.
United States of America
PMVP
United States of America
PMVP
Offers a Xenon gas drug-device for non-invasive, radiation-free MRI of lung function.
United States of America
POLX
United States of America
POLX
South Korea
041910
A global CDMO specializing in peptide and oligonucleotide APIs for pharma and biotech partners.
Switzerland
PPGN
Switzerland
PPGN
Develops localized, prolonged-release drug therapies for surgery, oncology & metabolic diseases.
United States of America
PYPD
United States of America
PYPD
Develops hydrogel nasal sprays for pathogen protection and intranasal drug delivery.
United States of America
PLRZ
United States of America
PLRZ
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom
POLB
United Kingdom
POLB
Developing therapies for CNS disorders using insights from genetic epilepsies.
United States of America
PRAX
United States of America
PRAX
Develops gene and cell therapies for difficult-to-treat diseases using precision technology.
United States of America
PGEN
United States of America
PGEN